{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:54:39Z","timestamp":1781740479680,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015994","name":"Higher Committee for Educational Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015994","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007640","name":"University of Sulaimani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102600","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:18:54Z","timestamp":1777043934000},"page":"102600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-6366","authenticated-orcid":false,"given":"Azad K.","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Triantafyllakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheema S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-8204","authenticated-orcid":false,"given":"Nicholas D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice P.","family":"Zeegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-099X","authenticated-orcid":false,"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102600_bib1","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J. Glob. Health"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102600_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/uro4030012","article-title":"Bladder cancer basic study and current clinical trials","volume":"4","author":"Godlewski","year":"2024","journal-title":"Uro"},{"key":"10.1016\/j.bbrep.2026.102600_bib3","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"Optimizing outcomes for high-risk, non-muscle-invasive bladder cancer: the evolving role of PD-(L) 1 inhibition","author":"Bedke","year":"2023"},{"issue":"7","key":"10.1016\/j.bbrep.2026.102600_bib4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.eursup.2009.06.010","article-title":"Recurrence, progression, and follow-up in non\u2013muscle-invasive bladder cancer","volume":"8","author":"van der Heijden","year":"2009","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.bbrep.2026.102600_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102600_bib6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/cancers13061396","article-title":"Imaging and management of bladder cancer","volume":"13","author":"Wong","year":"2021","journal-title":"Cancers"},{"issue":"27","key":"10.1016\/j.bbrep.2026.102600_bib7","doi-asserted-by":"crossref","first-page":"14340","DOI":"10.1074\/jbc.M115.707240","article-title":"Crystal structure of a two-domain fragment of hepatocyte growth factor activator inhibitor-1: functional interactions between the Kunitz-type inhibitor domain-1 and the neighboring polycystic kidney disease-like domain","volume":"291","author":"Hong","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102600_bib8","article-title":"The Kunitz domain I of hepatocyte growth factor activator inhibitor-2 inhibits matriptase activity and invasive ability of human prostate cancer cells","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102600_bib9","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.3390\/ijms19113435","article-title":"Hepatocyte growth factor activator: a proteinase linking tissue injury with repair","volume":"19","author":"Fukushima","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102600_bib10","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.3390\/jcm14113664","article-title":"Usability evaluation of urinary HAI-1, STMN-1 and TN-C in the diagnosis of bladder cancer","volume":"14","author":"Szyma\u0144ska","year":"2025","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102600_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0002-9440(10)64081-3","article-title":"Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo","volume":"158","author":"Oberst","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102600_bib12","first-page":"575","article-title":"Expression of Hepatocyte growth factor activator inhibitor type-1 (HAI-1) in prostate cancer","volume":"33","author":"Yasuda","year":"2013","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102600_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-017-3014-x","article-title":"Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma","volume":"10","author":"Sakugawa","year":"2017","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.bbrep.2026.102600_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13577-013-0074-7","article-title":"Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer","volume":"26","author":"Ye","year":"2013","journal-title":"Hum. Cell"},{"key":"10.1016\/j.bbrep.2026.102600_bib15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00268-010-0517-1","article-title":"Expression of hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma and postoperative outcomes","volume":"34","author":"Funagayama","year":"2010","journal-title":"World J. Surg."},{"key":"10.1016\/j.bbrep.2026.102600_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155809","article-title":"Loss of tumor cell surface hepatocyte growth factor activator inhibitor-1 predicts worse prognosis in esophageal squamous cell carcinoma","volume":"266","author":"Umekita","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102600_bib17","first-page":"239","article-title":"The role of hepatocyte growth factor activator inhibitor-1 (HAI-1) as a prognostic indicator in cervical cancer","volume":"35","author":"Nakamura","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102600_bib18","first-page":"345","article-title":"Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer","volume":"34","author":"Nakamura","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102600_bib19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.25606","article-title":"The role of hepatocyte growth factor activator inhibitor (HAI)\u20101 and HAI\u20102 in endometrial cancer","volume":"128","author":"Nakamura","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102600_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1078-0432.CCR-0553-3","article-title":"The hepatocyte growth factor regulatory factors in human breast cancer","volume":"10","author":"Parr","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102600_bib21","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.3390\/ijms19123708","article-title":"Matriptase-induced phosphorylation of MET is significantly associated with poor prognosis in invasive bladder cancer; an immunohistochemical analysis","volume":"19","author":"Yamasaki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102600_bib22","doi-asserted-by":"crossref","first-page":"C462","DOI":"10.1152\/ajpcell.00076.2005","article-title":"HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease","volume":"289","author":"Oberst","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102600_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.gendis.2020.12.001","article-title":"Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity","volume":"9","author":"Chiu","year":"2022","journal-title":"Genes Dis."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102600_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/biot.70141","article-title":"Overexpression of Matriptase\u20101 inhibitor HAI\u20101 as an effective strategy to reduce proteolytic clipping in Chinese hamster ovary cells","volume":"20","author":"Zhang","year":"2025","journal-title":"Biotechnol. J."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102600_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1349-7006.2011.02162.x","article-title":"Cleavage of hepatocyte growth factor activator inhibitor\u20101 by membrane\u2010type MMP\u20101 activates matriptase","volume":"103","author":"Domoto","year":"2012","journal-title":"Cancer Sci."},{"issue":"50","key":"10.1016\/j.bbrep.2026.102600_bib26","doi-asserted-by":"crossref","first-page":"20769","DOI":"10.1074\/jbc.M117.796789","article-title":"Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1","volume":"292","author":"Ishikawa","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102600_bib27","doi-asserted-by":"crossref","first-page":"C40","DOI":"10.1152\/ajpcell.00351.2005","article-title":"Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells","volume":"291","author":"Kiyomiya","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102600_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/pin.12647","article-title":"Hepatocyte growth factor activator inhibitors (HAI\u20101 and HAI\u20102): emerging key players in epithelial integrity and cancer","volume":"68","author":"Kataoka","year":"2018","journal-title":"Pathol. Int."},{"issue":"38","key":"10.1016\/j.bbrep.2026.102600_bib29","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.25397","article-title":"Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification","volume":"9","author":"Snell","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbrep.2026.102600_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1464-410X.2009.08849.x","article-title":"The West Midlands bladder cancer prognosis programme: rationale and design","volume":"105","author":"Zeegers","year":"2010","journal-title":"BJU Int."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102600_bib31","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/mc.23119","article-title":"A shift from membranous and stromal syndecan\u20101 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer","volume":"58","author":"Kind","year":"2019","journal-title":"Mol. Carcinog."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102600_bib32","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1111\/febs.16348","article-title":"Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor\u20101","volume":"289","author":"Yamashita","year":"2022","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102600_bib33","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/ijms27042000","article-title":"Membrane-anchored serine protease inhibitors: physiological functions, mechanisms, and roles in cancer","volume":"27","author":"Chen","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102600_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cas.12306","article-title":"Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model","volume":"105","author":"Ye","year":"2014","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102600_bib35","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","article-title":"A molecular taxonomy for urothelial carcinoma","volume":"18","author":"Sj\u00f6dahl","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102600_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/path.6062","article-title":"The lund taxonomy for bladder cancer classification\u2013from gene expression clustering to cancer cell molecular phenotypes, and back again","volume":"259","author":"H\u00f6glund","year":"2023","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102600_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1055-9965.EPI-05-0737","article-title":"A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1","volume":"15","author":"Saleem","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102600_bib38","first-page":"1101","article-title":"Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters","volume":"8","author":"Oberst","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102600_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/bbrc.2001.5916","article-title":"Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma","volume":"289","author":"Nagata","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102600_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00418-018-1660-2","article-title":"Expression of serine peptidase inhibitor Kunitz type 1 in differentiated thyroid cancer","volume":"149","author":"Liu","year":"2018","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102600_bib41","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"Gene network profiling in muscle-invasive bladder cancer: a systematic review and meta-analysis","author":"Isali","year":"2022"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:36:24Z","timestamp":1781739384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S2405580826001603"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102600","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102600"}}